CorMedix (CRMD) Cash & Current Investments (2010 - 2025)

CorMedix (CRMD) has 16 years of Cash & Current Investments data on file, last reported at $155.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments rose 200.27% year-over-year to $155.2 million; the trailing twelve-month figure through Dec 2025 stood at $155.2 million (up 200.27% YoY), and the FY2025 full-year result was $155.2 million, up 200.27% from the prior year.
• Cash & Current Investments improved to $155.2 million in Q4 2025, from $56.6 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $190.7 million in Q2 2025 to a low of $22.7 million in Q1 2022.
• A 5-year average of $65.9 million and a median of $57.6 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments soared 42266.88% in 2021 and plunged 72.03% in 2022, its largest moves.
• Tracing CRMD's Cash & Current Investments over 5 years: stood at $65.5 million in 2021, then sank by 33.9% to $43.3 million in 2022, then surged by 75.7% to $76.0 million in 2023, then plunged by 32.02% to $51.7 million in 2024, then soared by 200.27% to $155.2 million in 2025.
• Business Quant data shows CRMD's Cash & Current Investments at $155.2 million in Q4 2025, $56.6 million in Q3 2025, and $190.7 million in Q2 2025.